Search
for
Sort by
Research 631–660 of 641
- Clinicopathological characteristics of fibrosing alopecia in a pattern distribution: a single‐center, retrospective study
- An Updated in the Management of Alopecia Areata
- Recent Advances in Understanding of the Etiopathogenesis, Diagnosis, and Management of Hair Loss Diseases
- New Treatment Options for Alopecia Areata
- Recent advances in the genetics of alopecia areata
- Use of Contact Immunotherapy in the Treatment of Skin Diseases Other than Alopecia Areata
- Drug Armamentarium for alopecia areata
- 870 Y27632 promotes proliferation via EGFR signaling in a newly isolated and characterized human primary sebocyte cell line
- Phosphodiesterase (PDE) Inhibitors for the Treatment of Inflammatory Skin Conditions
- Tratamiento de la alopecia areata, un recorrido desde las opciones terapéuticas clásicas hasta los nuevos fármacos aparecidos en los últimos años
- Topical JAK Inhibitors for the Treatment of Alopecia Areata and Vitiligo
- The IL-23/IL-17 Pathway in Inflammatory Skin Diseases: From Bench to Bedside
- Extensive alopecia areata is reversed by IL-12/IL-23p40 cytokine antagonism
- 1318 Both lesional and non-lesional skin from acne patients shows robust IL-17-skewing and upregulation of antimicrobial peptides
- Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-γ-expressing Th1 cells and IL-17A/IL-22-expressing Th17 cells and respond to anti-IL-12/IL-23 antibody treatment
- Alopecia areata profiling shows TH1, TH2, and IL-23 cytokine activation without parallel TH17/TH22 skewing
- Targeting lymphoid-derived IL-17 signaling to delay skin aging
- Netherton syndrome subtypes share IL-17/IL-36 signature with distinct IFN-α and allergic responses
- CXCL12+ dermal fibroblasts promote neutrophil recruitment and host defense by recognition of IL-17
- The Immunological Impact of IL-1 Family Cytokines on the Epidermal Barrier
- IL-12/IL-23 neutralization is ineffective for alopecia areata in mice and humans
- Single‐cell transcriptomics reveals a senescence‐associated IL ‐6/ CCR6 axis driving radiodermatitis
- Evaluation of serum levels of IL-6, IL-10, and TNF-a in alopecia areata patients: A systematic review and meta-analysis
- Off-label dermatologic uses of IL-23 inhibitors
- A Case of Steatocystoma Multiplex in a Psoriatic Patient during Treatment with Anti-IL-12/23
- Cutaneous Adverse Reactions to IL-17 and IL-23 Inhibitors: A Clinical Review of Reaction Patterns
- Paradoxical Alopecia Areata Induced by IL‐17 and IL‐23 Inhibitors: A Systematic Review
- Hair Loss Associated With IL ‐17 and IL ‐23 Inhibitors: A Systematic Review
- Association of Serum IL-23 and IL-17 Levels with Alopecia Areata
- Association of Serum IL-23 and IL-17 Levels with Alopecia Areata